Medical News

RSS

Benitec prices initial public offering of 1,500,000 American Depositary Shares

Benitec Biopharma Limited, a clinical-stage biotechnology company, is pleased to announce the pricing of its U.S. initial public offering of 1,500,000 American Depositary Shares (ADSs), representing 30,000,000 fully paid ordinary shares of Benitec and warrants to purchase 500,000 ADSs, representing 10,000,000 fully paid ordinary shares, at a price of US$9.21 per ADS and US$0.01 per warrant.

18 Aug 2015

BioElectronics reports Q2 financial results, publishes market surveys of ActiPatch Therapy

BioElectronics Corporation, the maker of advanced drug-free consumer medical devices, today published on its second quarter financial results along with a market analysis of its long term follow up surveys of customers who are managing pain with ActiPatch Therapy.

18 Aug 2015

US-based clinical research spending drops 32%, show new data

Could the Sunshine Act be creating an unintentional downward trend in clinical research? An analysis of the U.S. government's Open Payments database shows that industry spending on U.S-based clinical research has dropped 32 percent in the first year-over-year comparison since Open Payments data started to be collected.

18 Aug 2015

Takeda's $2.37 billion settlement over Actos didn't attract enough claimants to participate in the deal

MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that Takeda Pharmaceutical Co.'s $2.37 billion settlement didn't attract enough claimants to participate in the deal, which said the company would fund the deal after 95% of claimants joined it.

18 Aug 2015

Scientists discover special brain mechanism that can retrieve unconscious memories

Some stressful experiences - such as chronic childhood abuse - are so overwhelming and traumatic, the memories hide like a shadow in the brain.

18 Aug 2015

Newly developed oxidation process uses ozone to degrade contaminants in water

At the Center for Research and Assistance in Technology and Design of the State of Jalisco (CIATEJ) at the east of Mexico, an oxidation process was developed that uses ozone to degrade contaminants in water that alter the synthesis, transport, action or elimination of natural hormones, responsible for maintain self-regulation of metabolic and reproductive processes in living beings.

18 Aug 2015

Omeros reports additional positive data from OMS721 Phase 2 trial for treatment of thrombotic microangiopathies

Omeros Corporation today announced additional positive data in the company's Phase 2 clinical trial of OMS721 for the treatment of thrombotic microangiopathies (TMAs). TMAs are a family of rare, debilitating and life-threatening disorders characterized by excessive thrombi (clots) – aggregations of platelets – in the microcirculation of the body's organs, most commonly the kidney and brain.

18 Aug 2015

Mylan sued in connection with ANDA filing for generic version of Zytiga

Mylan N.V. today confirmed that the company has been sued by BTG International Ltd., Janssen Biotech, Inc., Janssen Oncology, Inc., and Janssen Research & Development, LLC in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration for Abiraterone Acetate Tablets, 250 mg.

18 Aug 2015

Hi-Tech acquires LG Sciences brand of Sports Nutrition and Bodybuilding products

Hi-Tech Pharmaceuticals, a leading global provider of Sports Nutrition, Weight loss products, and Contract Manufacturing services, and LG Sciences, one of the premier Sports Nutrition and Bodybuilding brands in the United States, today announced that Hi-Tech has acquired LG Sciences brand of Sports Nutrition products and Bodybuilding products.

18 Aug 2015

Genalyte completes $44 million in Series C Financing round

Genalyte, Inc. announced today it has completed a Series C Financing round of $44 million, led by Khosla Ventures. The company is redefining diagnostics with a testing platform and microchip technology that can be utilized in physician offices. With the application of a single drop of blood to a silicon microchip, Genalyte's Maverick Detection System can offer a complete panel of diagnostic test results in fifteen minutes.

18 Aug 2015

Students around the world now have free access to simulation software from ANSYS

Students around the world now have free access to the same leading engineering simulation solutions used by top organizations and professional engineers to create the most advanced products on the planet, thanks to ANSYS.

18 Aug 2015

Researchers test new non-invasive technique that can accurately detect malignant melanoma

Researchers have developed a new non-invasive technique which can accurately detect malignant melanoma without a biopsy.

18 Aug 2015

DaVita HealthCare Partners hosts health and disaster preparedness fair in Colorado Springs

DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, is hosting a health and disaster preparedness fair on Saturday, Aug. 22, at the St. Francis Medical Center off Woodmen Road in Colorado Springs.

18 Aug 2015

Elsevier announces Gray's Anatomy Art Contest winners

Elsevier, a world-leading provider of scientific, technical and medical information products and services, and publisher of Gray's Anatomy, the world's most famous anatomical reference, has selected Amanda Lilleston of Ann Arbor, Mich., as the winner of the Gray's Anatomy Art Contest. Christopher Smith of Silver Springs, Md., was named runner-up.

18 Aug 2015

First patient enrolled in Phase II trial of ImmunoPulse IL-12 and pembrolizumab combination therapy

OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced enrollment of the first patient into the Phase II Investigator Sponsored Trial led by the University of California, San Francisco to assess the anti-tumor activity, safety, and tolerability of the combination of OncoSec's investigational therapy, ImmunoPulse IL-12, and Merck's approved anti-PD-1 agent, KEYTRUDA (pembrolizumab), in patients with unresectable metastatic melanoma.

18 Aug 2015

Researchers describe central role of mTOR in ageing and age-related diseases

For some, TOR may bring to mind a Celtic mountain or perhaps an Internet privacy group. In the world of molecular biology it's a cellular pathway that's found in everything from yeast to mammals.

18 Aug 2015

RPCI researchers create outreach effort to improve public's participation in biomedical research

Roswell Park Cancer Institute researchers, together with input from African-American community leaders in Buffalo, have created an outreach effort that provides racial/ethnic minority and medically underserved communities with educational programs regarding the public's participation in biomedical research. The program is the basis of a recent study published by a team of local collaborators.

18 Aug 2015

Avita Medical, University of Huddersfield partner to explore mechanism of Regenerative Epithelial Suspension

Avita Medical Ltd, a regenerative medicine company specialising in the treatment of wounds and skin defects, today announced that it has forged a partnership with the University of Huddersfield to explore the mechanism of Regenerative Epithelial Suspension (RESTM) - from Avita's ReCell device - to better understand its ability to effectively treat burns, hard-to-heal wounds and skin trauma.

18 Aug 2015

Intoxicated victims of sexual violence could accurately retain information from events

People are often concerned about the accuracy of testimony given by victims who were intoxicated during a sexual assault- but a new study by University of Leicester researchers has found that while alcohol intoxicated participants report fewer pieces of information about an assault, the information that they do provide is just as accurate as sober participants.

18 Aug 2015

Study reports results of genetic testing for 22 genetic causes of neonatal diabetes

Over a 10 year period, the time that babies receive genetic testing after being diagnosed with diabetes has fallen from over four years to under two months. Pinpointing the exact genetic causes of sometimes rare forms of diabetes is revolutionising healthcare for these patients.

18 Aug 2015

Medical News

Benitec prices initial public offering of 1,500,000 American Depositary Shares

BioElectronics reports Q2 financial results, publishes market surveys of ActiPatch Therapy

US-based clinical research spending drops 32%, show new data

Takeda's $2.37 billion settlement over Actos didn't attract enough claimants to participate in the deal

Scientists discover special brain mechanism that can retrieve unconscious memories

Newly developed oxidation process uses ozone to degrade contaminants in water

Omeros reports additional positive data from OMS721 Phase 2 trial for treatment of thrombotic microangiopathies

Mylan sued in connection with ANDA filing for generic version of Zytiga

Hi-Tech acquires LG Sciences brand of Sports Nutrition and Bodybuilding products

Genalyte completes $44 million in Series C Financing round

Students around the world now have free access to simulation software from ANSYS

Researchers test new non-invasive technique that can accurately detect malignant melanoma

DaVita HealthCare Partners hosts health and disaster preparedness fair in Colorado Springs

Elsevier announces Gray's Anatomy Art Contest winners

First patient enrolled in Phase II trial of ImmunoPulse IL-12 and pembrolizumab combination therapy

Researchers describe central role of mTOR in ageing and age-related diseases

RPCI researchers create outreach effort to improve public's participation in biomedical research

Avita Medical, University of Huddersfield partner to explore mechanism of Regenerative Epithelial Suspension

Intoxicated victims of sexual violence could accurately retain information from events

Study reports results of genetic testing for 22 genetic causes of neonatal diabetes

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News